查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
集群規則間隔短回文重複技術到 2030 年的全球市場預測：按產品、應用、最終用戶和地區進行分析
市場調查報告書
商品編碼
1383406

集群規則間隔短回文重複技術到 2030 年的全球市場預測：按產品、應用、最終用戶和地區進行分析

Clustered Regularly Interspaced Short Palindromic Repeats Technology Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，2023 年全球 Clustered Regular Interspace Short Palindromic Repetition（Clustered Regular Interspace Short Palindromic Repetition）技術市場規模將達到 36 億美元，預測期內年複合成長率為 17.6%。到2030 年將達到113 億美元，預測期間內年複合成長率為 17.6%。到2030 年將達到113 億美元，預測期內年複合成長率為 17.6%。到2030 年將達到113 億美元，預測期內年複合成長率為 17.6%。到2030 年將達到113 億美元。

成簇規則間隔短回文重複技術是商業性系統。成簇規則間隔短回文重複技術用於精確修改包括人類在內的多種生物體中的 DNA 序列，用於基因治療、藥物開發和農業進步等目的。簇狀規則間隔短回文重複技術的優點是準確度高、經濟實惠、效率高，使其成為基因編輯的革命性工具，在醫學、生物技術和科學研究領域具有巨大潛力。

根據麥克馬斯特大學2019年進行的一項研究，超過112萬男性患有血友病，其中40萬人患有嚴重血友病。

正在進行的臨床試驗不斷增加

這些臨床試驗反映了人們對應用成簇規則間隔短回文重複技術來開發遺傳性疾病、癌症和各種其他疾病的新治療方法的興趣和投資日益成長。隨著臨床試驗的進展，使用集群定期間隔短回文重複的治療方法的安全性和有效性檢驗，增加了法規、投資者和醫療保健提供者的信心。這不僅為可能的市場核准鋪平了道路，而且擴大了簇狀規則間隔短回文重複的應用範圍，使其成為醫學領域的變革力量。臨床試驗的數量表明該技術具有徹底改變醫療保健並支持未來市場成長的潛力。

聚集規則間隔短回文重複的高成本

集群規則空間短回文重複的應用所需的研究、設備和專業知識的初始投資可能令人望而卻步。此外，嚴格的品管、嚴格的測試和法規遵循的需求也會增加整體成本。與簇狀規則間隔短回文重複相關的智慧財產權的高額許可費用進一步加重了公司和研究機構的負擔。這些高昂的成本限制了集群規則間隔短回文重複技術的獲得，並抑制了創新和採用的步伐，特別是對於預算有限的小型研究機構和組織來說，這是有可能的。

增加政府和私人對集群規則間隔短回文重複技術的投資和資助

公共和私營部門增加的資金將促進集群規則間隔短回文重複應用的研究、開發和商業化。這種財政支持加速了創新，擴大了應用範圍，並提高了技術的可近性。它還促進學術機構、生物技術公司和製藥公司之間的合作，以在基因治療、農業和藥物研發等領域取得突破。此外，強力的財政支持將促進法規合規性和道德考慮，並確保負責任和安全地使用集群規則間隔短回文重複技術。

集群規則間隔短回文重複發展的法規障礙

以倫理、安全和智慧財產權問題為特徵的不斷發展的法規環境可能會顯著減緩群集規則間隔短回文重複應用的開發和商業化。各國嚴格的法規和不同的指導方針可能會給尋求銷售基於集群規則間隔短回文重複的產品的研究人員和公司帶來挑戰。圍繞人類基因編輯和農業潛在生態學影響的倫理爭論使法規環境更加複雜。智慧財產權糾紛和許可複雜性也阻礙了創新和市場進入。這些障礙限制了集群定期間隔短回文重複技術的採用速度和範圍，減緩了它們滿足關鍵醫療需求、徹底改變農業和推進科學研究的潛力。

COVID-19 的影響：

COVID-19 大流行對集群常規間隔短回文重複技術市場產生了各種影響。雖然它暫時擾亂了供應鏈和實驗室研究，但它也凸顯了快速、準確的基因組編輯技術的重要性。簇狀規則間隔短回文重複技術在診斷測試開發和疫苗研究中的潛力已得到證明。此外，疫情也加速了數位工具的採用以及遠端存取與集群定期空間短回文重複相關的研究，使科學家更容易繼續他們的工作。因此，簇狀規則間隔短回文重複技術有可能吸引大流行之外的應用的關注和資金，並促進研究、醫學和生物技術的成長和多樣化。

簇狀規則間隔短回文重複試劑盒和酵素部分預計在預測期內將是最大的

簇狀規則間隔的短回文重複試劑盒和酶片段預計將有良好的成長。這些重要工具為研究人員提供了精確基因組編輯所需的組件。成簇規則間隔短回文重複試劑盒通常包括引導 RNA、Cas9 蛋白和靶向 DNA 修飾所需的其他試劑。 Cas9 等酵素負責在特定位點切割 DNA。這些酶的現成可用性簡化了成簇規則間隔的短回文重複的工作流程，使它們在從基因治療和藥物研發到農業進步的廣泛應用中更加高效和準確，操作成為可能。這些試劑盒和酶的便利性和可用性正在推動集群規則間隔短回文重複技術在各個科學和工業領域的廣泛採用和持續成長。

預計農業部門在預測期內年複合成長率最高

預計農業部門在預測期內將呈現最快的年複合成長率。簇狀規則間隔短回文重複技術為作物改良和牲畜育種提供準確、高效的基因組編輯工具，正在徹底改變農業產業。簇狀規則間隔短回文重複技術能夠開發出增強對害蟲、疾病、不利環境條件的抵抗力並提高營養含量的基因改造作物。這項創新有可能提高作物產量、減少對化學農藥的需求並應對糧食安全挑戰。集群規則間隔短回文重複在農業中的應用為永續和更具彈性的糧食生產帶來了巨大的希望，並且可以為人口成長和氣候變遷面臨的全球挑戰提供重要的解決方案。這就是我們所提供的。

比最大的地區

預計北美市場在預測期內將繼續佔據大部分市場佔有率。該地區擁有強大的集群規則間隔短回文重複研究和應用生態系統，其特點是主要生物技術公司、學術機構和研究中心高度集中。該地區先進的基礎設施、對生命科學的大量投資以及支持性的法規環境促進了集群規則間隔短回文重複技術的快速創新。北美在臨床試驗、基因治療進展以及基於成簇規則間隔短回文重複的治療方法開發方面處於領先地位，使其成為生物技術突破的中心。強大的私人和公共資金以及熟練的人才庫使北美成為推動集群常規間隔短回文重複市場成長和多樣化的領導者。

複合年複合成長率最高的地區：

預計亞太地區在預測期內的年複合成長率最高。該地區人口的快速成長、醫療投資的增加以及對生物技術研究的日益關注正在推動集群規則間隔短回文重複技術的採用。該地區正在成為農業、醫學和生物技術創新應用的溫床，重點是基因組學和精準醫學。此外，包括中國和印度在內的亞太地區多個國家正在大力投資與集群規則空間短回文重複相關的研發，以促進該技術的擴展和商業化。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球集群規則間隔短回文重複技術市場：依產品

  • 介紹
  • 簇狀規則間隙短回文重複試劑盒和酶
  • 設計工具
  • 質粒和載體
  • 引導RNA (gRNA) 設計
  • 細胞株工程
  • 其他產品

第6章 全球集群規則間隔短回文重複技術市場：按應用

  • 介紹
  • 藥物研發發現與開發
  • 農業
  • 生物燃料
  • 其他用途

第7章 全球集群規則間隔短回文重複技術市場：依最終用戶分類

  • 介紹
  • 製藥和生物技術公司
  • 學術研究所
  • 受託研究機構（CRO）
  • 其他最終用戶

第8章 全球集群規則間隔短回文重複技術市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Agilent Technologies, INC.
  • Applied Stemcell
  • Beam Therapeutics, INC.
  • Caribou Biosciences
  • Cellecta, INC.
  • 簇狀規則間隔短回文重複 Therapeutics AG
  • Danaher Corporation
  • Editas Medicine
  • Genecopoeia, INC.
  • Genscript
  • Intellia Therapeutics INC.
  • Lonza Group Ltd.
  • Mammoth Biosciences INC.
  • Merck KGAA
  • Origene Technologies, INC.
  • Synthego Corporation
  • Thermo Fisher Scientific INC.
  • Toolgen INC.
  • Twist bioscience corp.
Product Code: SMRC24255

According to Stratistics MRC, the Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market is accounted for $3.6 billion in 2023 and is expected to reach $11.3 billion by 2030 growing at a CAGR of 17.6% during the forecast period. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology is the commercial ecosystem surrounding the utilization of CRISPR-based genome editing and gene manipulation techniques. CRISPR technology is used to precisely modify DNA sequences in various organisms, including humans, for purposes such as gene therapy, drug development, and agricultural advancements. Its advantages include its high precision, affordability, and efficiency, making it a revolutionary tool for gene editing with immense potential in healthcare, biotechnology, and scientific research.

According to a study conducted by McMaster University in 2019, over 1.12 million men had haemophilia, and of these 0.4 million had severe haemophilia.

Market Dynamics:

Driver:

Increasing number of ongoing clinical trials

These trials reflect the growing interest and investment in applying CRISPR technology to develop novel therapies for genetic disorders, cancer, and a range of other diseases. As more trials progress, they validate the safety and efficacy of CRISPR-based treatments, driving confidence among regulators, investors, and healthcare providers. This not only paves the way for potential market approvals but also expands the applications of CRISPR, making it a transformative force in the healthcare sector. The abundance of clinical trials signifies the technology's potential to revolutionize medical treatment and underscores its future market growth.

Restraint:

High costs of CRISPR

The initial investment in research, equipment, and specialized expertise required for CRISPR applications can be prohibitively expensive. Additionally, the need for stringent quality control, rigorous testing, and regulatory compliance adds to the overall cost. High licensing fees for CRISPR-related intellectual property can further burden companies and institutions. These elevated expenses can limit the accessibility of CRISPR technology, especially for smaller research entities and organizations with limited budgets, potentially impeding the pace of innovation and adoption.

Opportunity:

Growing government and private investments and funding for CRISPR technology

Increased financial support from both public and private sectors fosters research, development, and commercialization of CRISPR applications. This funding accelerates innovation, expands the range of applications, and enhances the technology's accessibility. It also stimulates collaboration between academic institutions, biotech companies, and pharmaceutical firms, leading to breakthroughs in areas like gene therapy, agriculture, and drug discovery. Moreover, robust financial backing promotes regulatory compliance and ethical considerations, ensuring the responsible and safe use of CRISPR technology, which is crucial for its long-term success and societal acceptance.

Threat:

Regulatory hurdles for CRISPR advancements

The evolving regulatory landscape, characterized by ethical, safety, and intellectual property concerns, can significantly slow down the development and commercialization of CRISPR applications. Stringent regulations and varying guidelines across different countries may create challenges for researchers and companies seeking to bring CRISPR-based products to market. Ethical debates surrounding gene editing in humans and potential ecological impacts in agriculture further complicate the regulatory environment. Intellectual property disputes and licensing complexities can also hinder innovation and market entry. These barriers may limit the speed and scope of CRISPR technology adoption, delaying its potential to address critical healthcare needs, revolutionize agriculture, and advance scientific research.

COVID-19 Impact:

The COVID-19 pandemic has had a mixed impact on the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market. While it temporarily disrupted supply chains and laboratory research, it also highlighted the importance of rapid, precise genome editing techniques. CRISPR technology's potential for diagnostic test development and vaccine research was prominently showcased. Moreover, the pandemic accelerated the adoption of digital collaboration tools and remote access to CRISPR-related research, making it easier for scientists to continue their work. As a result, CRISPR technology has gained greater attention and funding for applications beyond the pandemic, potentially expediting its growth and diversification in research, healthcare, and biotechnology.

The CRISPR kits & enzymes segment is expected to be the largest during the forecast period

The CRISPR kits & enzymes segment is expected to have a lucrative growth. These essential tools provide researchers with the necessary components for precise genome editing. CRISPR kits typically contain guide RNAs, Cas9 proteins, and other reagents needed for target DNA modification. Enzymes, like Cas9, are responsible for cleaving DNA at specific sites. Their ready availability simplifies the CRISPR workflow, enabling more efficient and accurate genetic manipulations for a wide range of applications, from gene therapy and drug discovery to agricultural advancements. The convenience and accessibility of these kits and enzymes drive the widespread adoption and continued growth of CRISPR technology in various scientific and industrial sectors.

The agriculture segment is expected to have the highest CAGR during the forecast period

The agriculture segment is anticipated to witness the fastest CAGR growth during the forecast period. CRISPR technology is revolutionizing the agricultural industry by offering precise and efficient genome editing tools for crop improvement and livestock breeding. It allows for the development of genetically modified crops with enhanced resistance to pests, diseases, and adverse environmental conditions, as well as improved nutritional content. This innovation has the potential to increase crop yields, reduce the need for chemical pesticides, and address food security challenges. CRISPR's applications in agriculture hold great promise for sustainable and more resilient food production, offering a crucial solution to global challenges in the face of a growing population and changing climate.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. It boasts a robust ecosystem for CRISPR research and applications, characterized by a concentration of leading biotech companies, academic institutions, and research centers. The region's advanced infrastructure, significant investment in life sciences, and supportive regulatory environment have fostered rapid innovation in CRISPR technology. North America has been at the forefront of clinical trials, gene therapy advancements, and the development of CRISPR-based therapies, making it a hub for biotechnological breakthroughs. The strong presence of private and public funding, along with a skilled talent pool, positions North America as a leader in driving the growth and diversification of the CRISPR market.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The region's rapidly growing population, rising healthcare investments, and increasing focus on biotechnology research have fuelled the adoption of CRISPR technology. It is becoming a hotbed for innovative applications across agriculture, healthcare, and biotechnology, with a strong emphasis on genomics and precision medicine. Furthermore, several countries in Asia Pacific, including China and India, are making substantial investments in CRISPR-related research and development, driving the technology's expansion and commercialization.

Key players in the market

Some of the key players in Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology market include: Agilent Technologies, INC., Applied Stemcell, Beam Therapeutics, INC., Caribou Biosciences, Cellecta, INC., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Genecopoeia, INC., Genscript, Intellia Therapeutics INC., Lonza Group Ltd., Mammoth Biosciences INC., Merck KGAA, Origene Technologies, INC., Synthego Corporation, Thermo Fisher Scientific INC., Toolgen INC. and Twist bioscience corp.

Key Developments:

In May 2023, Thermo Fisher Scientific opens cell therapy facility at UCSF to accelerate development of breakthrough therapies. Thermo Fisher Scientific Inc. and the University of California, San Francisco accelerated advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center's Mission Bay campus.

In April 2022, Thermo Fisher Scientific Inc. launched the new GMP-manufactured Gibco CTS TrueCut Cas9 Protein to support genome editing for research and manufacturing applications, including CAR T-cell therapy research.

In September 2022, GenScript announced today that it has launched the GenWand Double-Stranded DNA (dsDNA) Service for the manufacture of CRISPR knock-in homology- directed repair (HDR) templates in T cell engineering.

Products Covered:

  • CRISPR kits & Enzymes
  • Design Tools
  • Plasmid & Vector
  • Guide RNA (gRNA) Design
  • Cell Line Engineering
  • Other Products

Applications Covered:

  • Drug Discovery & Development
  • Agriculture
  • Biofuels
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By Product

  • 5.1 Introduction
  • 5.2 CRISPR kits & Enzymes
  • 5.3 Design Tools
  • 5.4 Plasmid & Vector
  • 5.5 Guide RNA (gRNA) Design
  • 5.6 Cell Line Engineering
  • 5.7 Other Products

6 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By Application

  • 6.1 Introduction
  • 6.2 Drug Discovery & Development
  • 6.3 Agriculture
  • 6.4 Biofuels
  • 6.5 Other Applications

7 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical & Biotechnology Companies
  • 7.3 Academic & Research Institutes
  • 7.4 Contract Research Organizations (CROs)
  • 7.5 Other End Users

8 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Agilent Technologies, INC.
  • 10.2 Applied Stemcell
  • 10.3 Beam Therapeutics, INC.
  • 10.4 Caribou Biosciences
  • 10.5 Cellecta, INC.
  • 10.6 CRISPR Therapeutics AG
  • 10.7 Danaher Corporation
  • 10.8 Editas Medicine
  • 10.9 Genecopoeia, INC.
  • 10.10 Genscript
  • 10.11 Intellia Therapeutics INC.
  • 10.12 Lonza Group Ltd.
  • 10.13 Mammoth Biosciences INC.
  • 10.14 Merck KGAA
  • 10.15 Origene Technologies, INC.
  • 10.16 Synthego Corporation
  • 10.17 Thermo Fisher Scientific INC.
  • 10.18 Toolgen INC.
  • 10.19 Twist bioscience corp.

List of Tables

  • Table 1 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 4 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 5 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 6 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 7 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 8 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 10 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 11 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 12 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 13 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 14 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 15 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 16 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 17 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 18 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 19 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 21 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 22 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 23 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 24 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 25 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 26 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 27 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 28 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 29 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 30 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 31 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 32 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 34 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 35 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 36 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 39 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 40 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 41 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 42 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 43 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 44 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 45 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 46 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 47 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 48 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 49 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 50 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 51 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 52 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 53 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 54 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 55 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 56 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 57 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 58 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 59 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 60 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 61 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 62 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 63 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 64 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 65 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 66 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 67 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 68 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 70 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 71 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 72 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 76 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 77 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 78 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 79 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 80 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 82 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 83 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 84 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 85 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 86 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 87 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 88 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 89 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 90 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 91 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 92 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 93 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 94 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 95 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 96 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 97 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 98 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 99 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 100 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 101 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 102 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 103 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 104 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 106 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 107 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 108 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)